Patent details

Basic Information

Publication number:

EP2896630

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151533734

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF

French Title of Invention:

ÉPITOPES DE LYMPHOCYTES T RÉGULATEURS, COMPOSITIONS ET LEURS UTILISATIONS

German Title of Invention:

REGULATORISCHE T-ZELLEN-EPITOPE SOWIE ZUSAMMENSETZUNGEN DAMIT UND ANWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

29/01/2008

Grant date:

23/12/2020

EP Publication Date:

22/07/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/12/2020

EP B1 Publication Date:

23/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/01/2021

Expiration date:

29/01/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/12/2020

 

 

Name:

Epivax, Inc.

Address:

188 Valley Street Suite 424, Providence, RI 02909, United States (US)

Inventor

1

Name:

De Groot, Anne

Address:

United States (US)

2

Name:

Rivera, Dan

Address:

United States (US)

3

Name:

Martin, William

Address:

United States (US)

Priority

Priority Number:

898347 P

Priority Date:

30/01/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/04; C07K 14/47; C07K 14/75; C07K 14/76; C07K 14/78; C07K 14/79;

Publication

European Patent Bulletin

Issue number:

202052

Publication date:

23/12/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages